Clinical Trial Update: A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MK-5684 in patients with certain solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK-5684 (MK-5684)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Malignant Neoplasm | Phase 2 | Status: RECRUITING